Legal status · United States
Is CT-868 legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. CT-868 is not approved for any medical use in the United States. Its legal category is "Investigational, not approved". The only legal way to get it is to join a registered clinical trial (an official study in people). A "research use only" label on vials sold online does not make them legal to use in people. On the evidence, 1 completed human trial is cited on its profile.
- People given it
- 103
- Found nothing
- 0
Legal category
Investigational, not approved
Never approved. Roche stopped work on it in July 2026 to focus on enicepatide, a once-a-week drug that acts on two hormone targets. Both drugs came to Roche when it bought Carmot.
Reviewed Sep 2026. This is a legal category, not legal advice.
A "research use only" label on a vial does not make it legal to use on people.
CT-868 in the United States at a glance
| Legal category | Investigational, not approved |
|---|---|
| Note | Never approved. Roche stopped work on it in July 2026 to focus on enicepatide, a once-a-week drug that acts on two hormone targets. Both drugs came to Roche when it bought Carmot. |
| FDA approval status | Not approved. Roche stopped work on it in July 2026, after the mid-stage study in type 2 diabetes. |
| Studies in people | 1 of 2 sources on the profile |
| Reviewed | Sep 2026 |
The legal category and note come from the CT-868 profile. We checked them against U.S. Food and Drug Administration (FDA) listings on the reviewed date.
What this means
- 01
CT-868 is being tested in registered clinical trials (official studies in people). FDA has not approved it for sale in the United States.
- 02
The only legal ways for a person to get it are to join a trial, or to use an official early-access program where one exists. There is no pharmacy product to prescribe.
- 03
Vials sold online "for research use only" are not trial supplies. That label does not make them legal to use in people.
What CT-868 is
In a mid-stage study of 103 adults with type 2 diabetes, it lowered average blood sugar (HbA1c) by 1.61 to 2.24 points more than a dummy shot. But weight fell only 2.9 percent more. Roche stopped the drug in July 2026 to focus on another drug from the same company purchase.
CT-868 came from Carmot Therapeutics in Berkeley. 1 billion dollars.
How it works: It works on two gut hormone switches, GLP-1 and GIP. Its makers call it fully biased.
Approval history: Not approved. Roche stopped work on it in July 2026, after the mid-stage study in type 2 diabetes.
How FDA treats this kind of product
Approves prescription drugs, each for a named use. It also acts against unapproved products, including peptides sold online. Compounding pharmacies, which mix drugs to order, may make some compounds with a prescription. That only applies when the FDA puts the compound in a category of bulk ingredients it allows.
The legal category above is how The Longevity Archive reads U.S. Food and Drug Administration listings for CT-868 on the reviewed date. It is not a legal opinion. Rules change. Bringing a compound into the country, prescribing it and owning it can each be treated differently. Check with the agency before you act on anything here.
CT-868 in sport and the military
Whether CT-868 is banned in sport is set by the World Anti-Doping Code and by military rules, not by its legal status in the United States. Before you compete or get tested, look up CT-868 by name on the Prohibited List, or look up a named product in Global DRO. Under the World Anti-Doping Code, category S0 bans, at all times, any drug-like substance that meets two tests. No other section of the List covers it. And no government health regulator anywhere has a current approval for it as a treatment in people. Many substances that are approved somewhere are banned by name in another section. So approval does not mean a substance is allowed in sport.
- WADA Prohibited List
- Global DRO (check a named product)
- USADA (US athletes)
- Operation Supplement Safety (US service members)
The rules you compete or serve under decide this, not this page.
CT-868 in other countries
Frequently asked questions
Is CT-868 legal in the United States?
No. CT-868 is not approved for any medical use in the United States. Its legal category is "Investigational, not approved". The only legal way to get it is to join a registered clinical trial (an official study in people). A "research use only" label on vials sold online does not make them legal to use in people. On the evidence, 1 completed human trial is cited on its profile. Note: Never approved. Roche stopped work on it in July 2026 to focus on enicepatide, a once-a-week drug that acts on two hormone targets. Both drugs came to Roche when it bought Carmot.
Can I buy CT-868 in the United States?
There is no approved product to buy. In the United States, CT-868 has the legal category "Investigational, not approved". So no licensed pharmacy product exists. Sellers who list it "for research use only" are not selling it for use in people, and that label does not change its legal status. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything. Note: Never approved. Roche stopped work on it in July 2026 to focus on enicepatide, a once-a-week drug that acts on two hormone targets. Both drugs came to Roche when it bought Carmot.
Is CT-868 FDA approved?
No. FDA status: Not approved. Roche stopped work on it in July 2026, after the mid-stage study in type 2 diabetes.. Current US legal category: "Investigational, not approved". On the evidence, 1 completed human trial is cited on its profile.
Related compounds in the United States
Full research profile
How CT-868 works, the studies we cite, FDA status and the full legal summary are all on its compound profile.
CT-868 profileThis page is general information about the legal status of CT-868 in the United States, current as of Sep 2026. It is not legal advice. Legal status changes. For your own situation, check with U.S. Food and Drug Administration or ask a lawyer. Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.